BodyBio Overview

  • Founded
  • 1995
Founded
  • Status
  • Private
  • Latest Deal Type
  • Debt - PPP

BodyBio General Information

Description

Provider of fatty acid research services intended to create dietary supplements. The company's services conduct lipids research and findings to the treatment and repair of physical ailments to make medical products which undergo extreme testing, enabling clients to access their products and services for a range of targeted high-quality vitamins and supplements.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Internet Retail
Primary Office
  • 45 Reese Road
  • Millville, NJ 08332
  • United States
+1 (888) 000-0000

BodyBio Timeline

2018201920202021
Financing RoundFinancing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BodyBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Debt - PPP 11-Apr-2020 00000 Completed
1. Angel (individual) 19-Jun-2019 00000 00000 Completed Generating Revenue
To view BodyBio’s complete valuation and funding history, request access »

BodyBio Executive Team (3)

Name Title Board Seat Contact Info
Edward Kane Co-Founder, Chief Executive Officer & Board Member
Bradley Berman Chief Operating Officer & President
Patricia Kane Ph.D Co-Founder
To view BodyBio’s complete executive team members history, request access »

BodyBio Board Members (3)

Name Representing Role Since
Edward Kane BodyBio Co-Founder, Chief Executive Officer & Board Member 000 0000
Paul Porecca BodyBio Board Member 000 0000
Seth Winter BodyBio Board Member 000 0000
To view BodyBio’s complete board members history, request access »